Bridgeway Capital Management’s Marker Therapeutics MRKR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-24,922
| Closed | -$92K | – | 1426 |
|
|
2022
Q3 | $92K | Hold |
24,922
| – | – | ﹤0.01% | 1290 |
|
|
2022
Q2 | $82K | Sell |
24,922
-7,500
| -23% | -$24.7K | ﹤0.01% | 1248 |
|
|
2022
Q1 | $143K | Hold |
32,422
| – | – | ﹤0.01% | 1226 |
|
|
2021
Q4 | $308K | Buy |
32,422
+3,500
| +12% | +$33.2K | 0.01% | 1097 |
|
|
2021
Q3 | $489K | Buy |
28,922
+12,700
| +78% | +$215K | 0.01% | 1035 |
|
|
2021
Q2 | $453K | Sell |
16,222
-2,885
| -15% | -$80.6K | 0.01% | 1093 |
|
|
2021
Q1 | $428K | Sell |
19,107
-715
| -4% | -$16K | 0.01% | 1133 |
|
|
2020
Q4 | $287K | Sell |
19,822
-2,500
| -11% | -$36.2K | 0.01% | 1129 |
|
|
2020
Q3 | $335K | Hold |
22,322
| – | – | 0.01% | 1027 |
|
|
2020
Q2 | $462K | Buy |
+22,322
| New | +$462K | 0.01% | 884 |
|